Gene: PCNX2

80003
PCNXL2
pecanex homolog 2
protein-coding
1q42.2
Ensembl:ENSG00000135749 MIM:617656 Vega:OTTHUMG00000037824 UniprotKB:A6NKB5
NG_050912.1
SNP Mapped
1   ANCO-SNPs
ND
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
3.794e-1 (AD)  6.675e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs2477859chr1:233145551 (GRCh38.p7)T>C / T>Gnicotine dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0067181,12-benzoperylene"1,12-benzoperylene results in increased expression of PCNX2 mRNA"26377693
D018501Antirheumatic AgentsAntirheumatic Agents results in increased expression of PCNX2 mRNA24449571
D001104ArbutinArbutin results in decreased expression of PCNX2 mRNA17103032
C006780bisphenol Abisphenol A results in decreased expression of PCNX2 mRNA25181051
D003703DemecolcineDemecolcine results in increased expression of PCNX2 mRNA23649840
D005020Ethyl MethanesulfonateEthyl Methanesulfonate results in increased expression of PCNX2 mRNA23649840
D005557FormaldehydeFormaldehyde results in increased expression of PCNX2 mRNA23649840
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in increased expression of PCNX2 mRNA23649840
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of PCNX2 mRNA"25554681
C006253pirinixic acidpirinixic acid results in decreased expression of PCNX2 mRNA20813756
D011285Pregnenolone CarbonitrilePregnenolone Carbonitrile results in increased expression of PCNX2 mRNA22698814
C009277sodium arsenatesodium arsenate results in decreased expression of PCNX2 mRNA21795629
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of PCNX2 mRNA19465110
C009495titanium dioxidetitanium dioxide results in increased expression of PCNX2 mRNA23557971
D014635Valproic AcidValproic Acid affects the expression of PCNX2 mRNA25979313
D014635Valproic AcidValproic Acid results in increased expression of PCNX2 mRNA19101580|2317975
D014750VincristineVincristine results in increased expression of PCNX2 mRNA23649840

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0003674molecular_function-ND-  
GO ID GO Term Qualifier Evidence PubMed
GO:0008150biological_process-ND-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005575cellular_component-ND-  
GO:0016021integral component of membrane-IEA-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

There is no Interaction data for this gene.

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal